Clarke Ronald sold $88.5M of CPAY

Clarke Ronald (CEO & Chairman of BOD) sold 213,860 shares of CORPAY, INC. (CPAY) at an average of $413.89 ($409.56–$419.62, $88.51M total) across 14 trades over 2026-08-24 to 2026-08-25.

Original reporting
SEC EDGAR · Clarke Ronald
Published Aug 26, 2026, 12:47 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 1:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CPAY
Bearish
medium confidence
Mentioned
$CPAY
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CPAYBearishMed
01

Why it matters

The transaction represents a material reduction in insider ownership, which may affect market perception.

02

Market read

Large insider sell could trigger short‑term price weakness; traders may adjust positions accordingly.

03

What to watch

Potential tax planning or diversification needs of the insider.

Relevance 8/10Novelty 8/10Timing: post-filing 2026-08-25

Background

Form 4 filing disclosed a multi‑day open‑market sale by the CEO.

Company-level read

Ticker impact

$CPAYBearishMedium confidence
Context

CEO Clarke Ronald sold 213,860 shares for $88.5M, reducing his stake to 2.35M shares.

Expected impact

Potential short-term downward pressure on CPAY stock.

Evidence & confidence

The $88.5M sale by the CEO is sizable and could be interpreted as lack of confidence, likely prompting traders to consider selling or hedging.

Market effects

May raise concerns for the fintech/payments sector if other insiders follow suit.

Limited to US markets where CPAY trades.

Minimal global impact beyond CPAY investors.

Counterpoint

The sale could be a routine liquidity event unrelated to company outlook.

Key entities

  • Clarke Ronald

    CEO & Chairman of the Board of Corpay, Inc.

  • Corpay, Inc.

    Provider of corporate payment solutions, ticker CPAY.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CPAYMed

What Corpay (CPAY) Said on Its Q3 Earnings Call

Corpay (CPAY) reported Q3 gross margin at 30.4%, up from Q2 but down annually. Cash position was CAD 50.6M. Acquired AISPECO for airborne sensors. Expects revenue synergies sooner. Plans to scale manufacturing and expand commercial/defense businesses. Corpay provides corporate payment solutions.

$CPAYMedAI 8/10

Corpay 3Q 2026: Revenue $1.38B, EPS $5.66 — 10-Q Summary

Corpay reported 3Q 2026 revenue of $1.38B, up 17.9% YoY, and net income of $378.42M, up 36.2% YoY. Growth was driven by organic spend and transaction volumes, new sales, and acquisitions. Higher operating expenses and other costs partly offset gains. Management expects liquidity to meet needs for the next 12 months.

$CPAYHighAI 8/10

Corpay (CPAY) Q3 2026 Earnings Call Transcript

Corpay (CPAY) raised Q4 2026 revenue guidance to $1.37B and cash EPS to $7.65, up 27%. Full-year 2026 revenue is expected to rise 18%, with cash EPS up over 30%. For 2027, Corpay anticipates 9-11% organic revenue growth. The company has divested noncore businesses, using proceeds for share buybacks, and plans to allocate $2B in free cash flow to acquisitions or buybacks. Corporate Payments segment growth is expected to remain in the high teens.

$CPAYMed

Corpay Q3 Earnings Call Highlights

Corpay (NYSE:CPAY) expects 9-11% organic revenue growth in 2027, with $2B in free cash flow for acquisitions or share repurchases. The company divested noncore businesses in 2026, using proceeds for buybacks. Alpha and Avid are expected to contribute over $1.40 in combined cash EPS accretion in 2026. Corpay aims to compound adjusted EPS by over 20% annually through 2029.